Free press releases distribution network?

Agency / Source: Advaita Corporation

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



iPathwayGuide Now Available in Illumina’s BaseSpace Apps - Advaita Bioinformatics today announced the addition of its iPathwayGuide application to BaseSpace Apps, Illumina’s applications store and informatics community dedicated to advancing genomic analysis - AdvaitaCorporation.com
iPathwayGuide Now Available in Illumina’s BaseSpace Apps

 

PRZOOM - /newswire/ - Plymouth, MI, United States, 2014/06/23 - Advaita Bioinformatics today announced the addition of its iPathwayGuide application to BaseSpace Apps, Illumina’s applications store and informatics community dedicated to advancing genomic analysis - AdvaitaCorporation.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

iPathwayGuide is a web based pathway analysis tool that goes beyond the typical statistical over-representation analysis by taking into account the pathway topology from a systems biology perspective. Advaita has demonstrated that this approach can significantly reduce the number of false positive and false negative results produced by most competing tools. iPathwayGuide also highlights coherent chains of perturbation propagation and drug targets directly on the pathway, so users can quickly focus on potential points of interest. The application provides quick access to a wide array of analyses including: gene analysis, gene-ontology analysis, pathway analysis, drug pathway mapping and disease associations. iPathwayGuide is the only gene-expression analysis tool that goes beyond simple associations and provides a deeper, richer, more comprehensive pathway level analysis.

“We are very excited to offer our iPathwayGuide application to the growing users of Illumina’s BaseSpace,” said Andrew Olson, VP of Business Development at Advaita. “The integration of our tool in BaseSpace will allow the users to seamlessly pipeline their gene expression data and perform a variety of analyses. iPathwayGuide is the most comprehensive systems biology tool available that considers the role and function of each gene to produce to produce biologically meaningful results.”

About Advaita

Advaita Bioinformatics (advaitabio.com), founded in 2005, is focusing on the mission to bridge the gap between the ability to collect biological data and the ability to interpret it through the use of advanced computational methods. Advaita's vision is to leverage advanced computational methods to dramatically reduce drug-development costs, make personalized medicine a clinical reality and shift the emphasis from treating disease to pre-symptomatic detection. Advaita’s analytical tools have helped researchers from premier organizations to translate gigabytes of experimental data into meaningful knowledge. iPathwayGuide is the first web application capable of identifying mechanisms of action and potential drug targets directly from gene-expression experiments. This unique ability can empower users to quickly identify potential drug targets and drug candidates, avoiding costly dead ends.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Advaita Corporation

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


iPathwayGuide Now Available in Illumina’s BaseSpace Apps

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Arjun Gupta - AdvaitaCorporation.com 
734-922-0110 info[.]advaitacorporation.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Advaita Corporation securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Advaita Corporation / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  RightITnow Ltd

Visit  JobsWare.com

Visit  NAKIVO, Inc.







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today